PHIOGEN

PHIOGEN has developed a world-first biotechnology platform designed to generate next-generation therapeutics utilizing naturally occurring bacteriophages for broad patient applications. Our platform allows high-throughput screening and development of phages to tackle drug-resistant, recurrent and life-threatening infections by evolving phages against resistant bacteria to make predictive and smart products, enabling doctors to have broad-spectrum antibacterials to treat infections. This innovative phage technology platform marks a significant medical breakthrough for countering the global threat of antimicrobial resistance.